Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

YTTRIUM Y-90: 134 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
134
Total FAERS Reports
33 (24.6%)
Deaths Reported
63
Hospitalizations
134
As Primary/Secondary Suspect
6
Life-Threatening
2
Disabilities

Active Ingredient: YTTRIUM CHLORIDE Y-90 ·

First Report: 200404 · Latest Report: 20250911

What Are the Most Common YTTRIUM Y-90 Side Effects?

#1 Most Reported
Abdominal pain
17 reports (12.7%)
#2 Most Reported
Off label use
15 reports (11.2%)
#3 Most Reported
Drug ineffective
14 reports (10.4%)

All YTTRIUM Y-90 Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Abdominal pain 17 12.7% 2 13
Off label use 15 11.2% 3 2
Disease progression 14 10.5% 5 1
Drug ineffective 14 10.5% 2 4
Metastases to liver 12 9.0% 9 2
Pyrexia 12 9.0% 1 11
Fatigue 11 8.2% 2 6
Thrombocytopenia 11 8.2% 4 2
Pancreatic carcinoma metastatic 10 7.5% 3 0
Pancreatic neuroendocrine tumour metastatic 9 6.7% 5 0
Vomiting 9 6.7% 1 7
Ascites 8 6.0% 2 7
Diarrhoea 8 6.0% 2 3
Malignant neoplasm progression 8 6.0% 7 0
Pancytopenia 8 6.0% 5 3
Cholangitis 7 5.2% 0 7
Dyspnoea 7 5.2% 1 4
Hepatic failure 7 5.2% 5 4
Neutropenia 7 5.2% 1 3
Product use in unapproved indication 7 5.2% 6 0

Who Reports YTTRIUM Y-90 Side Effects? Age & Gender Data

Gender: 31.0% female, 69.0% male. Average age: 59.1 years. Most reports from: US. View detailed demographics →

Is YTTRIUM Y-90 Getting Safer? Reports by Year

YearReportsDeathsHosp.
2004 4 2 3
2005 3 0 3
2006 3 2 0
2007 3 1 3
2008 4 1 2
2010 1 0 0
2011 1 0 0
2014 7 3 6
2015 8 2 7
2016 1 0 1
2018 3 1 3
2019 1 1 1
2020 6 0 0
2021 14 0 14
2022 1 0 0
2024 6 5 6
2025 2 0 1

View full timeline →

What Is YTTRIUM Y-90 Used For?

IndicationReports
Colorectal cancer metastatic 28
Hepatocellular carcinoma 19
Radiotherapy 11
Radioembolisation 9
Neuroendocrine tumour 8
Non-hodgkin's lymphoma 8
Pancreatic neuroendocrine tumour metastatic 6
Metastases to liver 5

YTTRIUM Y-90 vs Alternatives: Which Is Safer?

YTTRIUM Y-90 vs ZAFIRLUKAST YTTRIUM Y-90 vs ZALCITABINE YTTRIUM Y-90 vs ZALEPLON YTTRIUM Y-90 vs ZANAMIVIR YTTRIUM Y-90 vs ZANIDATAMAB YTTRIUM Y-90 vs ZANTAC YTTRIUM Y-90 vs ZANTAC 150 YTTRIUM Y-90 vs ZANUBRUTINIB YTTRIUM Y-90 vs ZAVEGEPANT YTTRIUM Y-90 vs ZEAXANTHIN

Official FDA Label for YTTRIUM Y-90

Official prescribing information from the FDA-approved drug label.